Scientific article
Open access

Cannabinoids and COVID-19

Publication date2020

Since the endocannabinoid system is involved in immune function, the effect of cannabinoid intake on infectious conditions is questioned for several years and is of particular interest in the COVID 19 pandemia. Some data suggest that the immunomodulatory effect of cannabinoids may affect the course and severity of SARS-CoV-2 infection. Given the large number of cannabinoids consumers in the community, this commentary presents the current knowledge on the potential impact of cannabinoids and endocannabinoids on bacterial and viral infection courses namely SARS-CoV-2 disease. Practical recommendations, which can be drawn from the literature, are given.

  • SARS-CoV-2
  • COVID-19
  • Immunity
  • Cannabinoids
  • Endocannabinoid system
Citation (ISO format)
EL BIALI, Myriam et al. Cannabinoids and COVID-19. In: Medical Cannabis and Cannabinoids, 2020, p. 1–5. doi: 10.1159/000510799
Main files (1)
Article (Published version)
ISSN of the journal2504-3889

Technical informations

Creation08/24/2020 4:55:00 PM
First validation08/24/2020 4:55:00 PM
Update time03/15/2023 10:53:19 PM
Status update03/15/2023 10:53:18 PM
Last indexation02/12/2024 1:19:47 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack